REIT - Residential
Compare Stocks
5 / 10Stock Comparison
BRT vs IIPR vs NHI vs REFI vs TPVG
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Industrial
REIT - Healthcare Facilities
REIT - Mortgage
Asset Management
BRT vs IIPR vs NHI vs REFI vs TPVG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Residential | REIT - Industrial | REIT - Healthcare Facilities | REIT - Mortgage | Asset Management |
| Market Cap | $276M | $1.64B | $3.65B | $252M | $234M |
| Revenue (TTM) | $98M | $263M | $403M | $60M | $97M |
| Net Income (TTM) | $-12M | $120M | $148M | $31M | $-12M |
| Gross Margin | 40.7% | 60.3% | 61.3% | 93.9% | 83.5% |
| Operating Margin | 6.1% | 46.7% | 48.5% | 25.3% | 77.9% |
| Forward P/E | — | 13.5x | 21.0x | 6.5x | 6.2x |
| Total Debt | $508M | $394M | $1.16B | $98M | $469M |
| Cash & Equiv. | $25M | $48M | $20M | $15M | $20M |
BRT vs IIPR vs NHI vs REFI vs TPVG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 21 | May 26 | Return |
|---|---|---|---|
| BRT Apartments Corp. (BRT) | 100 | 61.1 | -38.9% |
| Innovative Industri… (IIPR) | 100 | 21.8 | -78.2% |
| National Health Inv… (NHI) | 100 | 131.0 | +31.0% |
| Chicago Atlantic Re… (REFI) | 100 | 71.8 | -28.2% |
| TriplePoint Venture… (TPVG) | 100 | 32.1 | -67.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BRT vs IIPR vs NHI vs REFI vs TPVG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BRT is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 217.1% 10Y total return vs IIPR's 439.9%
- Lower volatility, beta 0.60, current ratio 0.86x
- Beta 0.60, yield 7.2%, current ratio 0.86x
- Beta 0.60 vs IIPR's 0.91
IIPR carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 3.60 vs TPVG's 6.14
- Lower P/E (13.5x vs 21.0x)
- 13.3% yield, 9-year raise streak, vs TPVG's 17.8%
- +16.6% vs REFI's -6.8%
NHI ranks third and is worth considering specifically for efficiency.
- 5.4% ROA vs BRT's -1.7%, ROIC 5.6% vs 1.3%
REFI is the clearest fit if your priority is income & stability.
- Dividend streak 0 yrs, beta 0.70, yield 17.1%
- 51.8% margin vs BRT's -12.5%
TPVG is the clearest fit if your priority is growth exposure.
- Rev growth 36.6%, EPS growth 48.8%
- 36.6% NII/revenue growth vs IIPR's -13.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 36.6% NII/revenue growth vs IIPR's -13.8% | |
| Value | Lower P/E (13.5x vs 21.0x) | |
| Quality / Margins | 51.8% margin vs BRT's -12.5% | |
| Stability / Safety | Beta 0.60 vs IIPR's 0.91 | |
| Dividends | 13.3% yield, 9-year raise streak, vs TPVG's 17.8% | |
| Momentum (1Y) | +16.6% vs REFI's -6.8% | |
| Efficiency (ROA) | 5.4% ROA vs BRT's -1.7%, ROIC 5.6% vs 1.3% |
BRT vs IIPR vs NHI vs REFI vs TPVG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
BRT vs IIPR vs NHI vs REFI vs TPVG — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NHI leads in 2 of 6 categories
TPVG leads 1 • BRT leads 0 • IIPR leads 0 • REFI leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NHI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NHI is the larger business by revenue, generating $403M annually — 6.8x REFI's $60M. REFI is the more profitable business, keeping 51.8% of every revenue dollar as net income compared to BRT's -12.5%. On growth, NHI holds the edge at +29.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $98M | $263M | $403M | $60M | $97M |
| EBITDAEarnings before interest/tax | $33M | $197M | $282M | $15M | -$22M |
| Net IncomeAfter-tax profit | -$12M | $120M | $148M | $31M | -$12M |
| Free Cash FlowCash after capex | $13M | $144M | $226M | $24M | -$59M |
| Gross MarginGross profit ÷ Revenue | +40.7% | +60.3% | +61.3% | +93.9% | +83.5% |
| Operating MarginEBIT ÷ Revenue | +6.1% | +46.7% | +48.5% | +25.3% | +77.9% |
| Net MarginNet income ÷ Revenue | -12.5% | +45.6% | +36.8% | +51.8% | +50.6% |
| FCF MarginFCF ÷ Revenue | +13.0% | +54.7% | +56.1% | +40.9% | -58.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +4.2% | -3.8% | +29.7% | +16.3% | — |
| EPS Growth (YoY)Latest quarter vs prior year | -16.7% | -1.0% | +10.8% | -51.1% | -2.3% |
Valuation Metrics
TPVG leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 4.7x trailing earnings, TPVG trades at a 81% valuation discount to NHI's 24.9x P/E. Adjusting for growth (PEG ratio), IIPR offers better value at 3.89x vs TPVG's 4.67x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $276M | $1.6B | $3.6B | $252M | $234M |
| Enterprise ValueMkt cap + debt − cash | $759M | $2.0B | $4.8B | $336M | $683M |
| Trailing P/EPrice ÷ TTM EPS | -22.21x | 14.58x | 24.92x | 7.12x | 4.73x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 13.49x | 20.97x | 6.50x | 6.23x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.89x | — | — | 4.67x |
| EV / EBITDAEnterprise value multiple | 20.29x | 10.01x | 17.20x | 9.32x | 9.02x |
| Price / SalesMarket cap ÷ Revenue | 2.84x | 6.16x | 9.64x | 4.00x | 2.41x |
| Price / BookPrice ÷ Book value/share | 1.49x | 0.88x | 2.30x | 0.83x | 0.66x |
| Price / FCFMarket cap ÷ FCF | 41.53x | 9.37x | 16.56x | 8.76x | — |
Profitability & Efficiency
NHI leads this category, winning 3 of 9 comparable metrics.
Profitability & Efficiency
NHI delivers a 9.8% return on equity — every $100 of shareholder capital generates $10 in annual profit, vs $-7 for BRT. IIPR carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to BRT's 2.87x. On the Piotroski fundamental quality scale (0–9), NHI scores 6/9 vs BRT's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -6.8% | +6.4% | +9.8% | +0.0% | -3.4% |
| ROA (TTM)Return on assets | -1.7% | +5.1% | +5.4% | +0.0% | -1.5% |
| ROICReturn on invested capital | +1.3% | +4.3% | +5.6% | +6.9% | +7.2% |
| ROCEReturn on capital employed | +1.6% | +5.8% | +8.0% | +9.3% | +9.4% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 4 | 6 | 4 | 4 |
| Debt / EquityFinancial leverage | 2.87x | 0.21x | 0.76x | 0.32x | 1.33x |
| Net DebtTotal debt minus cash | $483M | $346M | $1.1B | $83M | $449M |
| Cash & Equiv.Liquid assets | $25M | $48M | $20M | $15M | $20M |
| Total DebtShort + long-term debt | $508M | $394M | $1.2B | $98M | $469M |
| Interest CoverageEBIT ÷ Interest expense | 0.51x | 6.67x | 3.45x | 4.77x | -1.02x |
Total Returns (Dividends Reinvested)
Evenly matched — IIPR and NHI each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NHI five years ago would be worth $13,248 today (with dividends reinvested), compared to $5,308 for IIPR. Over the past 12 months, IIPR leads with a +16.6% total return vs REFI's -6.8%. The 3-year compound annual growth rate (CAGR) favors NHI at 20.2% vs TPVG's -1.9% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +3.1% | +19.6% | -0.9% | +1.4% | -9.6% |
| 1-Year ReturnPast 12 months | +1.8% | +16.6% | +4.0% | -6.8% | +7.4% |
| 3-Year ReturnCumulative with dividends | +0.6% | +15.1% | +73.9% | +28.2% | -5.6% |
| 5-Year ReturnCumulative with dividends | +10.9% | -46.9% | +32.5% | +26.7% | -15.2% |
| 10-Year ReturnCumulative with dividends | +217.1% | +439.9% | +59.2% | +26.7% | +91.2% |
| CAGR (3Y)Annualised 3-year return | +0.2% | +4.8% | +20.2% | +8.6% | -1.9% |
Risk & Volatility
Evenly matched — IIPR and NHI each lead in 1 of 2 comparable metrics.
Risk & Volatility
NHI is the less volatile stock with a -0.09 beta — it tends to amplify market swings less than IIPR's 0.91 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IIPR currently trades 93.3% from its 52-week high vs TPVG's 76.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.60x | 0.91x | -0.09x | 0.70x | 0.77x |
| 52-Week HighHighest price in past year | $16.69 | $61.40 | $90.94 | $15.20 | $7.53 |
| 52-Week LowLowest price in past year | $13.18 | $44.58 | $68.80 | $10.74 | $4.48 |
| % of 52W HighCurrent price vs 52-week peak | +87.8% | +93.3% | +82.8% | +78.7% | +76.6% |
| RSI (14)Momentum oscillator 0–100 | 62.1 | 56.4 | 33.9 | 43.1 | 67.6 |
| Avg Volume (50D)Average daily shares traded | 54K | 297K | 329K | 171K | 501K |
Analyst Outlook
Evenly matched — IIPR and TPVG each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BRT as "Buy", IIPR as "Hold", NHI as "Hold", REFI as "Buy", TPVG as "Hold". Consensus price targets imply 55.1% upside for TPVG (target: $9) vs 13.5% for NHI (target: $85). For income investors, TPVG offers the higher dividend yield at 17.76% vs NHI's 4.79%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $21.00 | $84.67 | $85.40 | $17.00 | $8.95 |
| # AnalystsCovering analysts | 5 | 11 | 18 | 6 | 12 |
| Dividend YieldAnnual dividend ÷ price | +7.2% | +13.3% | +4.8% | +17.1% | +17.8% |
| Dividend StreakConsecutive years of raises | 0 | 9 | 1 | 0 | 0 |
| Dividend / ShareAnnual DPS | $1.05 | $7.62 | $3.61 | $2.05 | $1.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.8% | +1.2% | 0.0% | 0.0% | 0.0% |
NHI leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). TPVG leads in 1 (Valuation Metrics). 3 tied.
BRT vs IIPR vs NHI vs REFI vs TPVG: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BRT or IIPR or NHI or REFI or TPVG a better buy right now?
For growth investors, TriplePoint Venture Growth BDC Corp.
(TPVG) is the stronger pick with 36. 6% revenue growth year-over-year, versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). TriplePoint Venture Growth BDC Corp. (TPVG) offers the better valuation at 4. 7x trailing P/E (6. 2x forward), making it the more compelling value choice. Analysts rate BRT Apartments Corp. (BRT) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BRT or IIPR or NHI or REFI or TPVG?
On trailing P/E, TriplePoint Venture Growth BDC Corp.
(TPVG) is the cheapest at 4. 7x versus National Health Investors, Inc. at 24. 9x. On forward P/E, TriplePoint Venture Growth BDC Corp. is actually cheaper at 6. 2x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innovative Industrial Properties, Inc. wins at 3. 60x versus TriplePoint Venture Growth BDC Corp. 's 6. 14x.
03Which is the better long-term investment — BRT or IIPR or NHI or REFI or TPVG?
Over the past 5 years, National Health Investors, Inc.
(NHI) delivered a total return of +32. 5%, compared to -46. 9% for Innovative Industrial Properties, Inc. (IIPR). Over 10 years, the gap is even starker: IIPR returned +439. 9% versus REFI's +26. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BRT or IIPR or NHI or REFI or TPVG?
By beta (market sensitivity over 5 years), National Health Investors, Inc.
(NHI) is the lower-risk stock at -0. 09β versus Innovative Industrial Properties, Inc. 's 0. 91β — meaning IIPR is approximately -1114% more volatile than NHI relative to the S&P 500. On balance sheet safety, Innovative Industrial Properties, Inc. (IIPR) carries a lower debt/equity ratio of 21% versus 3% for BRT Apartments Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — BRT or IIPR or NHI or REFI or TPVG?
By revenue growth (latest reported year), TriplePoint Venture Growth BDC Corp.
(TPVG) is pulling ahead at 36. 6% versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). On earnings-per-share growth, the picture is similar: TriplePoint Venture Growth BDC Corp. grew EPS 48. 8% year-over-year, compared to -28. 8% for Innovative Industrial Properties, Inc.. Over a 3-year CAGR, BRT leads at 11. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BRT or IIPR or NHI or REFI or TPVG?
Chicago Atlantic Real Estate Finance, Inc.
(REFI) is the more profitable company, earning 57. 1% net margin versus -12. 3% for BRT Apartments Corp. — meaning it keeps 57. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus 11. 4% for BRT. At the gross margin level — before operating expenses — IIPR leads at 88. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BRT or IIPR or NHI or REFI or TPVG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innovative Industrial Properties, Inc. (IIPR) is the more undervalued stock at a PEG of 3. 60x versus TriplePoint Venture Growth BDC Corp. 's 6. 14x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, TriplePoint Venture Growth BDC Corp. (TPVG) trades at 6. 2x forward P/E versus 21. 0x for National Health Investors, Inc. — 14. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TPVG: 55. 1% to $8. 95.
08Which pays a better dividend — BRT or IIPR or NHI or REFI or TPVG?
All stocks in this comparison pay dividends.
TriplePoint Venture Growth BDC Corp. (TPVG) offers the highest yield at 17. 8%, versus 4. 8% for National Health Investors, Inc. (NHI).
09Is BRT or IIPR or NHI or REFI or TPVG better for a retirement portfolio?
For long-horizon retirement investors, National Health Investors, Inc.
(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 09), 4. 8% yield). Both have compounded well over 10 years (NHI: +59. 2%, TPVG: +91. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BRT and IIPR and NHI and REFI and TPVG?
These companies operate in different sectors (BRT (Real Estate) and IIPR (Real Estate) and NHI (Real Estate) and REFI (Real Estate) and TPVG (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: BRT is a small-cap income-oriented stock; IIPR is a small-cap deep-value stock; NHI is a small-cap income-oriented stock; REFI is a small-cap high-growth stock; TPVG is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.